Literature DB >> 2947668

The blood-brain barrier in Alzheimer's disease.

H V Vinters, W M Pardridge.   

Abstract

The current evidence for and against abnormalities of the blood-brain barrier in "normal" aging and Alzheimer's disease is reviewed. Recent studies of cerebral amyloid angiopathy, a microangiopathy commonly observed in Alzheimer's disease and one suggested to result from blood-brain barrier derangement, are discussed with particular attention to the biochemical nature of the vascular amyloid material, and features it shares with the amyloid found in senile plaque cores and with neurofibrillary tangles. Modern techniques that will probably clarify blood-brain barrier pathophysiology are reviewed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947668     DOI: 10.1017/s0317167100037094

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.

Authors:  R A Armstrong; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2010-01-29       Impact factor: 8.090

2.  Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease.

Authors:  T I Mandybur
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.

Authors:  R A Armstrong; D Myers; C U Smith
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.

Authors:  L Frölich; J Kornhuber; R Ihl; J Fritze; K Maurer; P Riederer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

5.  Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.

Authors:  Brian R Ott; Richard N Jones; Lori A Daiello; Suzanne M de la Monte; Edward G Stopa; Conrad E Johanson; Charles Denby; Paula Grammas
Journal:  Front Aging Neurosci       Date:  2018-08-21       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.